Here's Why Ginkgo Bioworks (DNA) is Poised for a Turnaround After Losing -28.84% in 4 Weeks

Group 1 - Ginkgo Bioworks Holdings, Inc. (DNA) has experienced a significant decline of 28.8% over the past four weeks, but it is now in oversold territory, indicating a potential trend reversal [1] - The Relative Strength Index (RSI) for DNA is currently at 20.73, suggesting that the heavy selling pressure may be exhausting itself, which could lead to a reversal towards the previous equilibrium of supply and demand [5] - There is strong consensus among Wall Street analysts that DNA will report better earnings than previously predicted, with the consensus EPS estimate increasing by 37.9% over the last 30 days [7] Group 2 - DNA holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, indicating a strong potential for a turnaround [8]